Kiniksa Pharmaceuticals International reported cash from operations of $47.20M and free cash flow of $46.53M for the quarter ended Jun 2026, up 68.0% year over year. This cash flow statement covers 37 quarters of results from Jun 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||||||||||||||||||
| Net Income | -30.54M | -44.08M | -25.21M | -19.98M | 224.09M | 88.53M | -12.27M | 14.97M | -13.86M | -49.24M | -17.70M | -3.91M | -12.69M | -8.89M | 8.54M | 17.83M | 18.43M | 14.20M | 22.59M | 25.43M | |||||||||||||||||
| Share-based CompensationStock Comp. | 9.56M | 6.13M | 8.79M | 9.57M | 10.32M | 6.37M | 10.08M | 10.96M | 11.63M | 7.77M | 11.24M | 11.78M | 11.63M | 8.30M | 10.99M | 10.83M | 11.90M | 10.23M | 10.06M | 11.64M | |||||||||||||||||
| Deferred Taxes | 0.35M | 1.08M | -19.44M | 10.29M | -25.71M | 4.37M | 10.57M | -3.64M | 0.65M | 2.99M | 2.64M | 4.23M | 6.06M | 4.52M | 2.66M | ||||||||||||||||||||||
| Cash from OperationsCash from Ops. | -28.51M | -18.88M | -36.85M | -7.82M | 62.05M | -11.58M | -4.27M | -3.74M | 16.99M | 4.33M | 3.99M | 5.17M | -2.24M | 18.77M | 22.32M | 28.09M | 33.68M | 53.89M | 50.20M | 47.20M | |||||||||||||||||
| Depreciation, Depletion & Amortization | |||||||||||||||||||||||||||||||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | -0.01M | -0.05M | -0.16M | -0.08M | 0.12M | 0.20M | 1.06M | 1.15M | -1.44M | 0.30M | -0.30M | 0.19M | 0.49M | -0.82M | -0.26M | 0.84M | -0.60M | 0.93M | -1.30M | -0.09M | |||||||||||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 0.66M | 0.67M | 0.66M | 0.65M | 0.49M | 0.60M | 0.60M | 0.60M | 0.60M | 0.54M | 0.47M | 0.43M | 0.40M | 0.40M | 0.34M | 0.36M | 0.38M | 0.47M | 0.47M | 0.47M | |||||||||||||||||
| Change in Working Capital | |||||||||||||||||||||||||||||||||||||
| Change in ReceivablesChange Receivables | 0.67M | 0.69M | 25.45M | -21.63M | 3.35M | 1.50M | -5.24M | 17.23M | -21.61M | 18.23M | -5.27M | 4.46M | 4.44M | 16.84M | -1.66M | -8.15M | 19.83M | -36.15M | 7.63M | 0.27M | |||||||||||||||||
| Change in InventoryChange Inventory | -0.78M | -1.93M | 9.55M | 6.69M | -5.29M | 6.98M | 1.83M | 0.53M | 1.62M | 5.54M | -3.84M | 7.58M | -6.18M | -2.32M | -4.29M | 26.11M | -6.79M | 13.50M | 18.25M | -2.21M | |||||||||||||||||
| Change in Account PayablesChange Payables | -2.54M | 0.25M | 1.51M | -0.86M | -1.05M | 6.43M | -6.51M | -0.74M | 0.36M | 7.23M | -2.66M | 1.73M | 0.91M | -6.28M | 0.06M | 6.93M | -2.73M | -4.12M | 22.27M | -12.00M | |||||||||||||||||
| Change in Accured ExpensesChange Accured Exp. | -2.46M | 10.04M | 4.08M | -5.97M | 1.97M | -3.79M | -10.65M | 14.69M | 7.61M | 5.29M | 3.29M | 18.66M | 10.80M | 10.99M | -3.60M | 13.10M | 8.37M | 19.63M | -5.05M | 25.79M | |||||||||||||||||
| Investing Activities | |||||||||||||||||||||||||||||||||||||
| Capital ExpendituresCapex | 0.78M | 2.23M | -2.75M | -0.16M | -0.00M | 0.27M | -3.27M | 0.09M | -1.41M | 3.36M | 3.84M | 0.01M | 2.52M | -2.04M | 0.07M | 0.14M | 3.40M | 0.16M | 0.66M | ||||||||||||||||||
| Sales of Property, Plant and EquipmentPP&E (Sale) | -0.01M | 0.01M | |||||||||||||||||||||||||||||||||||
| Change in Acquisitions & DivestmentsChange Acquisitions | 47.90M | 10.00M | 7.50M | 63.80M | 36.40M | 20.10M | 15.00M | 73.70M | 40.83M | 45.98M | 61.88M | 42.44M | 48.13M | 87.48M | 44.03M | 30.61M | 84.08M | 40.78M | 145.66M | 36.70M | |||||||||||||||||
| Cash from Investing ActivitiesCash from Investing | 47.85M | -50.04M | -22.72M | 38.27M | 19.04M | -42.66M | -37.92M | 35.53M | -12.28M | -14.89M | 25.52M | -46.80M | -6.35M | 65.29M | -51.54M | -3.88M | -62.76M | -70.81M | -31.92M | -73.58M | |||||||||||||||||
| Financing Activities | |||||||||||||||||||||||||||||||||||||
| Other financing activitiesOther financing | 2.68M | 1.21M | 0.99M | 0.57M | 0.57M | 1.29M | 0.51M | 0.58M | 1.66M | 0.96M | 3.99M | 1.14M | 9.40M | 2.72M | 3.18M | 12.74M | 16.25M | 8.58M | 6.39M | 17.58M | |||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | 2.68M | 1.21M | 0.42M | 0.54M | 0.36M | 1.19M | 0.09M | 0.16M | 0.55M | 0.69M | 3.61M | -0.18M | 6.69M | 2.14M | 2.77M | 10.70M | 11.90M | 7.66M | 6.07M | 12.11M | |||||||||||||||||
| Change in Capital Stock | |||||||||||||||||||||||||||||||||||||
| Net Shares Issued and RepurchasedNet Shares Issued | 2.60M | 0.50M | 2.93M | 0.09M | 2.13M | 0.12M | 0.13M | 2.06M | 0.10M | ||||||||||||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | |||||||||||||||||||||||||||||||||||||
| Additional items | |||||||||||||||||||||||||||||||||||||
| Change in Cash | 22.02M | -67.71M | -59.15M | 30.98M | 81.45M | -53.05M | -42.10M | 31.95M | 5.26M | -9.87M | 33.12M | -41.81M | -1.90M | 86.20M | -26.45M | 34.91M | -17.18M | -9.26M | 24.36M | -14.28M | |||||||||||||||||
| Free Cash FlowFCF | -29.29M | -21.11M | -34.09M | -7.66M | 62.05M | -11.84M | -1.00M | -3.83M | 16.99M | 5.73M | 0.62M | 1.33M | -2.25M | 16.25M | 24.37M | 28.02M | 33.53M | 50.49M | 50.04M | 46.53M | |||||||||||||||||
| Net Cash FlowNCF | 22.02M | -67.71M | -59.15M | 30.98M | 81.45M | -53.05M | -42.10M | 31.95M | 5.26M | -9.87M | 33.12M | -41.81M | -1.90M | 86.20M | -26.45M | 34.91M | -17.18M | -9.26M | 24.36M | -14.28M |